Showing results (121-130 of 316) with videos related to

Sort By:
Pageof 32
International Journal of Cancer|February 6, 2003
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinomaDo-Sun Byun, Kyucheol Cho, Byung-Kyu Ryu, et al.
ACS Applied Materials & Interfaces|November 30, 2018
Wireless Real-Time Temperature Monitoring of Blood Packages: Silver Nanowire-Embedded Flexible Temperature SensorsDoo-Young Youn, Uihyun Jung, Muhammad Naqi, et al.
Cancer Research|January 31, 2016
RASSF1A Directly Antagonizes RhoA Activity through the Assembly of a Smurf1-Mediated Destruction Complex to Suppress TumorigenesisMin-Goo Lee, Seong-In Jeong, Kyung-Phil Ko, et al.
Plos One|April 23, 2016
Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean InstitutionHyung Soon Park, Sun Min Lim, Sora Kim, et al.
Chem|January 20, 2025
Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable ProdrugAmit Sharma, Min-Goo Lee, Hu Shi, et al.
Immunology|April 13, 2007
Sphingosine kinase inhibitor suppresses dendritic cell migration by regulating chemokine receptor expression and impairing p38 mitogen-activated protein kinaseIn Duk Jung, Jun Sik Lee, Yong Joo Kim, et al.
Psychiatry Research|September 25, 2010
Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHDSung Hee Lee, So Won Kim, Min Goo Lee, et al.
The Journal of Biological Chemistry|January 19, 2010
BetaPix up-regulates Na+/H+ exchanger 3 through a Shank2-mediated protein-protein interactionJung-Soo Lee, Young Mee Lee, Joo Young Kim, et al.
BMC Cancer|November 17, 2017
Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progressionByung-Kyu Ryu, Min-Goo Lee, Nam-Hoon Kim, et al.
Pharmacogenetics and Genomics|November 9, 2020
A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylatorsHyounggyoon Yoo, Sang Chun Ji, Joo-Youn Cho, et al.
Pageof 32